SETD4 and breast carcinoma: More broadly, our models using diapause embryos of Artemia, human breast cancer stem cells (CSCs), and other contexts have their focus upon an evolutionarily conserved mechanism of cellular quiescence which is epigenetically regulated by facilitating heterochromatin formation with Set domain-containing protein 4 (Setd4) as a determinant14,15.